A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered Twice-Daily for 3 months in Adult Subjects with Stable Patchy Alopecia Areata
|Effective start/end date||8/1/17 → 8/30/21|
- ACLARIS THERAPEUTICS, INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.